Emerging from the global pandemic, the vitality and dynamism of AsiaPacific’s supercomputing sector is almost palpable. From climate modeling to precision medicine, the frontiers of human knowledge are constantly being challenged—and this pursuit is not looking like it’s losing momentum any time soon.

Dennis Lo was announced as the sole winner of the 2022 Lasker-DeBakey Clinical Medical Research Award for his discovery of fetal DNA in maternal blood that led to non-invasive testing for chromosomal abnormalities.

From performing outsourced research and manufacturing generics, Asia's biomedical researchers are now among the world's most innovative.

Lo received the Breakthrough Prize in Life Sciences for developing noninvasive genetic fetal screening tests used by millions of prospective parents worldwide.

Having seen non-invasive prenatal testing grow from an idea to an actual product, Professor Dennis Lo shares why he thinks Asia is the best place to be for his next venture: liquid biopsies for cancer.

Even when faced with setbacks at turning points in his career, Lo persisted in his research, developing non-invasive prenatal diagnostic tests that are now used around the world.

Detecting cancers with a blood test sounds simple enough, but is it just hype or are liquid biopsies here to stay?

Professor Xue Qi-Kun shares the story behind his discovery of quantum anomalous Hall effect and other developments in the field of condensed matter physics.

How much closer are we to achieving distance running’s holy grail?